Although these results suggest that CHTM1 is deregulated in both squamous cell carcinomas and adenocarcinomas, further studies using a larger cohort of patient samples will provide further insight into the relative expression status of CHTM1 in these histological types. The gene discussed is CHCHD5; the disease is squamous cell carcinoma.